MiNK Therapeutics announced that it has regained compliance with the Nasdaq Capital Market’s market value of listed securities, MVLS, requirement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INKT: